Understanding Sickle cell disease: Causes, symptoms, and treatment options

被引:15
|
作者
Elendu, Chukwuka [1 ]
Amaechi, Dependable C. [2 ]
Alakwe-Ojimba, Chisom E. [3 ]
Elendu, Tochi C. [4 ]
Elendu, Rhoda C. [5 ]
Ayabazu, Chiagozie P. [6 ]
Aina, Titilayo O. [6 ]
Aborisade, Ooreofe [7 ]
Adenikinju, Joseph S. [8 ]
机构
[1] Fed Univ Teaching Hosp, Owerri, Nigeria
[2] Igbined Univ Okada, Okada, Nigeria
[3] Chukwuemeka Odumegwu Ojukwu Univ, Anambra State, Nigeria
[4] Imo State Univ, Owerri, Nigeria
[5] Van Horbachevsky Ternopil Natl Med Univ, Ternopol, Ukraine
[6] Babcock Univ, Ogun State, Nigeria
[7] Olabisi Onabanjo Univ Teaching Hosp, Shagamu, Nigeria
[8] Northwick Pk Hosp London Northwest NHS Trust, London, England
关键词
acute chest syndrome; disease-modifying therapies; hematopoietic stem cell transplantation; Sickle cell disease; stroke; vaso-occlusive crisis; ACUTE CHEST SYNDROME; ANEMIA; HEMOGLOBIN; TRANSPLANTATION; EPIDEMIOLOGY; PATHOGENESIS; TRANSFUSIONS; HYDROXYUREA; HEMOLYSIS; CHILDREN;
D O I
10.1097/MD.0000000000035237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell disease (SCD) is a hereditary blood disorder characterized by the production of abnormal hemoglobin molecules that cause red blood cells to take on a crescent or sickle shape. This condition affects millions of people worldwide, particularly those of African, Mediterranean, Middle Eastern, and South Asian descent. This paper aims to provide an overview of SCD by exploring its causes, symptoms, and available treatment options. The primary cause of SCD is a mutation in the gene responsible for producing hemoglobin, the protein that carries oxygen in red blood cells. This mutation has abnormal hemoglobin called hemoglobin S, which causes red blood cells to become stiff and sticky, leading to various health complications. Patients with SCD may experience recurrent pain, fatigue, anemia, and increased infection susceptibility. Treatment options for SCD focus on managing symptoms and preventing complications. This includes pain management with analgesics, hydration, and blood transfusions to improve oxygen delivery. Hydroxyurea, a medication that increases the production of fetal hemoglobin, is commonly used to reduce the frequency and severity of pain crises. Additionally, bone marrow or stem cell transplants can cure select individuals with severe SCD. Finally, understanding the causes, symptoms, and treatment options for SCD is crucial for healthcare professionals, patients, and their families. It enables early diagnosis, effective symptom management, and improved quality of life for individuals with this chronic condition.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Treatment Options for Sickle Cell Disease
    Meier, Emily Riehm
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2018, 65 (03) : 427 - +
  • [2] Sickle Cell Disease: Current Understanding and Future Options
    Varelas, Christos
    Gavriilaki, Eleni
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [3] New Therapeutic Options for the Treatment of Sickle Cell Disease
    Matte, Alessandro
    Zorzi, Francesco
    Mazzi, Filippo
    Federti, Enrica
    Olivieri, Oliviero
    De Franceschi, Lucia
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [4] Sickle cell disease: time for a closer look at treatment options?
    Sheth, Sujit
    Licursi, Maureen
    Bhatia, Monica
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) : 455 - 464
  • [5] Symptoms, causes, and treatment options of geriatric nose
    Sieron, H. L.
    Sommer, F.
    Lindemann, J.
    Scheithauer, M. O.
    Wagenmann, M.
    Stupp, F.
    Hoffmann, T. K.
    [J]. HNO, 2021, 69 (12) : 1019 - 1032
  • [6] Sickle cell disease: Pulmonary management options
    Graham, LM
    [J]. PEDIATRIC PULMONOLOGY, 2004, : 191 - 193
  • [7] Genetic Testing for Dysplasia: Causes, Symptoms, and Treatment Options
    Umeda, Hashimoto
    [J]. JOURNAL OF THE PANCREAS, 2023, 24 (02): : 45 - 46
  • [8] An overview of pathophysiology and treatment options of osteonecrosis of femoral head in sickle cell disease
    Al-Otaibi, Mohammed L.
    [J]. SAUDI MEDICAL JOURNAL, 2022, 43 (11) : 1192 - 1199
  • [9] Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease
    Wanjiku, Christopher
    Njuguna, Cyrus Githinji
    Lazris, David
    Xu, Julia
    Njuguna, Festus
    Okuku, Austin
    MacDonald, Katherine
    [J]. BLOOD, 2023, 142
  • [10] Understanding the Complications of Sickle Cell Disease
    Tanabe, Paula
    Spratling, Regena
    Smith, Dana
    Grissom, Peyton
    Hulihan, Mary
    [J]. AMERICAN JOURNAL OF NURSING, 2019, 119 (06) : 26 - 35